Biotec Pharma is a global leader in clinical supply services, today announced a deal to acquire a clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan, from Teva-Takeda Pharmaceuticals, Nagoya Aichi, Japan. This purchase will establish a new clinical GMP manufacturing and distribution hub to support clinical studies. Financial details of the deal, which is expected to close on July 1, 2020, have not been disclosed.
The 60,000-square-foot facility will be the largest in the company’s Asia Pacific clinical supply network. The new facility will offer customers access to Biotec Pharma’s FastChain® demand-led supply services, primary and secondary packaging capabilities, a range of temperature options for storage and distribution, as well as clinical returns and destruction services. It will operate in partnership with Biotec Pharma’s existing Japanese clinical supply facility at Kakegawa, serving both local customers as well as global biotech and pharmaceutical companies.
